Wednesday, November 15th, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Event overview
Drug development processes become more efficient, in terms of time and cost, with the assistance of modeling and simulation approaches widely utilized and accepted in the pharmaceutical industry. In addition, they are highly supported by regulators.
This presentation provides decision makers with an overview as to “why” modeling and simulation is important in the drug development industry. Several real-world examples that address the “what” approaches and explain “how” these approaches should be conducted to enhance the drug development process will be highlighted during the webinar.
Three key take-aways
Getting the right outcomes from your clinical trials is all about the data and insights they provide. Biostatistics in clinical trials isn’t just a necessity, it can be a real competitive advantage.
.svg){kind=icon}
